Dr. Paul Melaragno, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $278.22 | 6 | 76.1% |
| Consulting Fee | $87.19 | 1 | 23.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $117.83 | 1 | $0 (2024) |
| DePuy Synthes Sales Inc. | $100.88 | 1 | $0 (2017) |
| Zimmer Biomet Holdings, Inc. | $87.19 | 1 | $0 (2022) |
| CONMED Corporation | $21.74 | 1 | $0 (2020) |
| Heron Therapeutics, Inc. | $13.61 | 1 | $0 (2021) |
| Pacira Pharmaceuticals Incorporated | $13.08 | 1 | $0 (2017) |
| Novo Nordisk Inc | $11.08 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.83 | 1 | Stryker Corporation ($117.83) |
| 2022 | $87.19 | 1 | Zimmer Biomet Holdings, Inc. ($87.19) |
| 2021 | $13.61 | 1 | Heron Therapeutics, Inc. ($13.61) |
| 2020 | $21.74 | 1 | CONMED Corporation ($21.74) |
| 2018 | $11.08 | 1 | Novo Nordisk Inc ($11.08) |
| 2017 | $113.96 | 2 | DePuy Synthes Sales Inc. ($100.88) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Stryker Corporation | — | Food and Beverage | In-kind items and services | $117.83 | General |
| 03/29/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device), Persona, mymobility Platform | Consulting Fee | Cash or cash equivalent | $87.19 | General |
| Category: Knees | ||||||
| 08/11/2021 | Heron Therapeutics, Inc. | Zynrelef (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Postoperative Pain | ||||||
| 01/13/2020 | CONMED Corporation | CONMED GENERATORS (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: GENERAL SURGERY | ||||||
| 10/12/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Diabetes | ||||||
| 07/26/2017 | DePuy Synthes Sales Inc. | — | Food and Beverage | In-kind items and services | $100.88 | General |
| 01/26/2017 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,150 | 2,064 | $676,161 | $173,943 |
| 2022 | 14 | 1,255 | 2,046 | $673,323 | $189,233 |
| 2021 | 15 | 1,178 | 1,813 | $674,041 | $189,123 |
| 2020 | 14 | 1,107 | 1,584 | $553,880 | $150,720 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2023 | 95 | 106 | $416,835 | $104,555 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 83 | $21,090 | $7,560 | 35.8% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 177 | 218 | $24,400 | $7,452 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 127 | $22,655 | $7,164 | 31.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 110 | 143 | $37,125 | $6,713 | 18.1% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 185 | 227 | $21,330 | $6,284 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $19,030 | $6,221 | 32.7% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 13 | 16 | $22,535 | $6,144 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 86 | 86 | $20,800 | $5,621 | 27.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 12 | 188 | $18,800 | $5,535 | 29.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 12 | 79 | $9,480 | $2,814 | 29.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 75 | $9,750 | $2,597 | 26.6% |
| 73721 | Mri scan of leg joint without contrast | Office | 2023 | 24 | 26 | $16,250 | $2,364 | 14.5% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 42 | 44 | $4,792 | $1,432 | 29.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,820 | $603.46 | 33.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 97 | 554 | $7,756 | $449.95 | 5.8% |
| 73501 | X-ray of hip, 1 view | Office | 2023 | 24 | 24 | $1,713 | $433.34 | 25.3% |
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2022 | 91 | 97 | $381,510 | $97,414 | 25.5% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 26 | 40 | $56,000 | $26,407 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 108 | $27,210 | $9,692 | 35.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 144 | 186 | $47,925 | $9,398 | 19.6% |
| 73564 | X-ray of knee, 4 or more views | Office | 2022 | 180 | 272 | $27,200 | $8,903 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 133 | $23,575 | $8,291 | 35.2% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 193 | 270 | $24,300 | $7,847 | 32.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 87 | 87 | $19,575 | $6,786 | 34.7% |
About Dr. Paul Melaragno, MD
Dr. Paul Melaragno, MD is a Adult Reconstructive Orthopaedic Surgery healthcare provider based in Upper Arlington, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770593279.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Melaragno, MD has received a total of $365.41 in payments from pharmaceutical and medical device companies, with $117.83 received in 2024. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($278.22).
As a Medicare-enrolled provider, Melaragno has provided services to 4,690 Medicare beneficiaries, totaling 7,507 services with total Medicare billing of $703,019. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Adult Reconstructive Orthopaedic Surgery
- Location Upper Arlington, OH
- Active Since 08/08/2006
- Last Updated 02/03/2025
- Taxonomy Code 207XS0114X
- Entity Type Individual
- NPI Number 1770593279
Products in Payments
- ROSA (Device) $87.19
- CONMED GENERATORS (Device) $21.74
- Zynrelef (Drug) $13.61
- EXPAREL (Drug) $13.08
- Tresiba (Drug) $11.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.